Cargando…

Association Between Proton Pump Inhibitors and Asthma: A Population-Based Cohort Study

OBJECTIVE: The relationship between proton pump inhibitors (PPIs) and asthma is controversial. The goal of this study was to determine the association between PPI use in non-asthma subjects and their subsequent asthma prevalence. DESIGN: Nationwide, population-based cohort study. METHODS: We conduct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yao-Tung, Tsai, Ming-Chang, Wang, Yu-Hsun, Wei, James Cheng-Chung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227244/ https://www.ncbi.nlm.nih.gov/pubmed/32457614 http://dx.doi.org/10.3389/fphar.2020.00607

Ejemplares similares

Associations Between Asthma Diagnosis/Asthma Exacerbation and Previous Proton-Pump Inhibitor use: A Nested Case-Control Study Using a National Health Screening Cohort
por: Choi, Hyo Geun, et al.
Publicado: (2022)

The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based Study
por: Shafrir, Asher, et al.
Publicado: (2022)

Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study
por: Peng, Yen-Chun, et al.
Publicado: (2018)

Proton Pump Inhibitors Were Associated With Reduced Pseudocysts in Acute Pancreatitis: A Multicenter Cohort Study
por: Zhang, Shengyu, et al.
Publicado: (2021)

Proton Pump Inhibitors and Cancer: Current State of Play
por: Bridoux, Marie, et al.
Publicado: (2022)

Population-based cohort study on the risk of pneumonia in patients with non-traumatic intracranial haemorrhage who use proton pump inhibitors
por: Ho, Sai-Wai, et al.
Publicado: (2014)

Proton Pump Inhibitors in IPF: A Call for Clinical Trials
por: Ghebre, Yohannes T.
Publicado: (2018)

Proton-pump inhibitor use amongst patients with severe hypomagnesemia
por: Seah, Sherry, et al.
Publicado: (2023)

Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan
por: Cheng, Kao-Chi, et al.
Publicado: (2017)

Clinical Intervention Increases Rational Use of Proton Pump Inhibitors in the General Surgery Department
por: Chen, Qiying, et al.
Publicado: (2022)

The Association Between Usage of Colchicine and Pneumonia: A Nationwide, Population-Based Cohort Study
por: Tsai, Tsung-Lin, et al.
Publicado: (2019)

Proton Pump Inhibitors Display Antitumor Effects in Barrett's Adenocarcinoma Cells
por: Chueca, Eduardo, et al.
Publicado: (2016)

A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children
por: Dipasquale, Valeria, et al.
Publicado: (2022)

Do proton pump inhibitors affect the effectiveness of chemotherapy in colorectal cancer patients? A systematic review with meta-analysis
por: Lin, Wan-Ying, et al.
Publicado: (2022)

Association between Proton Pump Inhibitor Use and CNS Infection Risk: A Retrospective Cohort Study
por: Hung, Wei-Te, et al.
Publicado: (2018)

Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy
por: Ikemura, Kenji, et al.
Publicado: (2017)

Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes
por: Lazzerini, Pietro E., et al.
Publicado: (2018)

Use of Proton Pump Inhibitors in Hungary: Mixed-Method Study to Reveal Scale and Characteristics
por: Matuz, Mária, et al.
Publicado: (2020)

Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota
por: Tian, Liang, et al.
Publicado: (2023)

Exposure to Proton Pump Inhibitors and the Risk of Incident Asthma in Patients with Coronary Artery Diseases: A Population-Based Cohort Study
por: Lin, Tsung-Kun, et al.
Publicado: (2022)

When does proton pump inhibitor treatment become long term? A scoping review
por: Haastrup, Peter Fentz, et al.
Publicado: (2021)

The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism
por: Gao, Nanyong, et al.
Publicado: (2022)

A Prescribing Cascade of Proton Pump Inhibitors Following Anticholinergic Medications in Older Adults With Dementia
por: Trenaman, Shanna C., et al.
Publicado: (2022)

Inhibition of Tryptophan Hydroxylases and Monoamine Oxidase-A by the Proton Pump Inhibitor, Omeprazole—In Vitro and In Vivo Investigations
por: Betari, Nibal, et al.
Publicado: (2020)

Association of proton pump inhibitors with gastric and colorectal cancer risk: A systematic review and meta-analysis
por: Guo, Huizhu, et al.
Publicado: (2023)

Evaluating physicians’ awareness and prescribing trends regarding proton pump inhibitors: a cross-sectional study
por: Swed, Sarya, et al.
Publicado: (2023)

Adding Chinese Herbal Medicine to Routine Care is Associated With a Lower Risk of Rheumatoid Arthritis Among Patients With Asthma: A Population-Based Retrospective Cohort Study
por: Chang, Wei-Chiao, et al.
Publicado: (2022)

Clinical Outcomes of Concomitant Use of Proton Pump Inhibitors and Dual Antiplatelet Therapy: A Systematic Review and Meta-Analysis
por: Guo, Hongzhou, et al.
Publicado: (2021)

Using proton pump inhibitors increases the risk of hepato-biliary-pancreatic cancer. A systematic review and meta-analysis
por: Zhou, Wence, et al.
Publicado: (2022)

Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line Helicobacter pylori agents
por: Kakiuchi, Toshihiko
Publicado: (2023)

Traditional Chinese medicine use is associated with lower risk of pneumonia in patients with systemic lupus erythematosus: a population-based retrospective cohort study
por: Wang, Weijie, et al.
Publicado: (2023)

Long-term proton pump inhibitors use and its association with premalignant gastric lesions: a systematic review and meta-analysis
por: Zheng, Zeyi, et al.
Publicado: (2023)

Proton Pump Inhibitor and Tacrolimus Uses are Associated With Hypomagnesemia in Connective Tissue Disease: a Potential Link With Renal Dysfunction and Recurrent Infection
por: Hanaoka, Hironari, et al.
Publicado: (2021)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Standard-Dose Proton Pump Inhibitors in the Initial Non-eradication Treatment of Duodenal Ulcer: Systematic Review, Network Meta-Analysis, and Cost-Effectiveness Analysis
por: Zhang, Jiaxing, et al.
Publicado: (2019)

Effect of proton pump inhibitors on the risk of chronic kidney disease: A propensity score-based overlap weight analysis using the United Kingdom Biobank
por: Zhang, Xing-Yu, et al.
Publicado: (2022)

Effects of CYP2C19 genetic polymorphisms on the cure rates of H. pylori in patients treated with the proton pump inhibitors: An updated meta-analysis
por: Zhao, Xianghong, et al.
Publicado: (2022)

Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
por: Poulsen, A H, et al.
Publicado: (2009)

Regular proton pump inhibitor use and incident dementia: population-based cohort study
por: Zhang, Peidong, et al.
Publicado: (2022)

Influence of Cytochrome P450 2C19 Genotype on Helicobacter pylori Proton Pump Inhibitor-Amoxicillin-Clarithromycin Eradication Therapy: A Meta-Analysis
por: Morino, Yuko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7chj0455nn7l1q1983ba5ji0ta